Expressions of TGF-β1 and VEGF in patients with acute myeloid leukemia and associations with prognosis Cover

.blurhash-client-img { display: none !important; }

Expressions of TGF-β1 and VEGF in patients with acute myeloid leukemia and associations with prognosis

Revista Romana de Medicina de Laborator

Volume 30 (2022): Issue 3 (July 2022)

By: Yan Xu, Xianqiu Yu and Xinlong Zhang

Open Access

|Jul 2022

Authors

Yan Xu

Hematology, The People’s Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, China

Xianqiu Yu

Hematology, Affiliated Hospital of Jiangsu University, China

Xinlong Zhang

obmaknonsreseb@gmx.com

Hematology, The People’s Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, China

DOI: https://doi.org/10.2478/rrlm-2022-0026 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624

Journal RSS Feed

Language: English

Page range: 273 - 280

Submitted on: Nov 26, 2021

Accepted on: Jun 6, 2022

Published on: Jul 18, 2022

Published by: Romanian Association of Laboratory Medicine

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

acute myeloid leukemia,

Related subjects:

Molecular biology,

Microbiology and virology

© 2022 Yan Xu, Xianqiu Yu, Xinlong Zhang, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous article Volume 30 (2022): Issue 3 (July 2022)Next article